ArticleFrontiers in oncology2022

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide.

Alessia Lodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.